Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × Toremifene × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 Prostatic Neoplasms 3 Neoplasms, Hormone-Dependent 3 Carcinoma, Lobular 3 Carcinoma, Ductal, Breast 3 Prostatic Intraepithelial Neoplasia 2 Fractures, Bone 2 Desmoid Tumors 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Osteoporosis 1 Neoplasms 1 Neoplasm Metastasis 1 Hormone-receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Carcinoma In Situ 1 Breast Cancer Patients in Premenopausal 1 Breast Cancer Organoids 1 Bone Diseases, Metabolic 1

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡